{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:01:11Z","timestamp":1762542071691},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.ejca.2012.01.035","type":"journal-article","created":{"date-parts":[[2012,3,5]],"date-time":"2012-03-05T17:31:32Z","timestamp":1330968692000},"page":"1672-1681","source":"Crossref","is-referenced-by-count":30,"title":["Incidence of fractures causing hospitalisation in prostate cancer patients: Results from the population-based PCBaSe Sweden"],"prefix":"10.1016","volume":"48","author":[{"given":"Andreas","family":"Thorstenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Bratt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olof","family":"Akre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Hellborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Holmberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Lambe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bill-Axelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4r","family":"Stattin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Adolfsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejca.2012.01.035_b0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/02841860802167490","article-title":"Fracture risk in patients with different types of cancer","volume":"48","author":"Vestergaard","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2012.01.035_b0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000176049","article-title":"Testosterone, bone and osteoporosis","volume":"37","author":"Tuck","year":"2009","journal-title":"Front Horm Res"},{"issue":"4","key":"10.1016\/j.ejca.2012.01.035_b0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1464-410X.2007.07163.x","article-title":"Fracture risk in Danish men with prostate cancer: a nationwide register study","volume":"100","author":"Abrahamsen","year":"2007","journal-title":"BJU Int"},{"issue":"6 Pt 1","key":"10.1016\/j.ejca.2012.01.035_b0020","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ju.0000143930.73016.c6","article-title":"Hip fractures in men with prostate cancer treated with orchiectomy","volume":"172","author":"Dickman","year":"2004","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ejca.2012.01.035_b0025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJMoa041943","article-title":"Risk of fracture after androgen deprivation for prostate cancer","volume":"352","author":"Shahinian","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejca.2012.01.035_b0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/pcan.2011.7","article-title":"Mortality following bone metastasis and skeletal-related events among men with prostate cancer: a population-based analysis of US Medicare beneficiaries, 1999\u20132006","volume":"14","author":"Sathiakumar","year":"2011","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"10.1016\/j.ejca.2012.01.035_b0035","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.294.2.238","article-title":"Androgen deprivation therapy for prostate cancer","volume":"294","author":"Sharifi","year":"2005","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.ejca.2012.01.035_b0040","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-4295(02)01677-1","article-title":"Critical evaluation of hormonal therapy for carcinoma of the prostate","volume":"60","author":"Chodak","year":"2002","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.ejca.2012.01.035_b0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM199707313370502","article-title":"Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin","volume":"337","author":"Bolla","year":"1997","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ejca.2012.01.035_b0050","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/cncr.20955","article-title":"Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma","volume":"103","author":"Shahinian","year":"2005","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2012.01.035_b0055","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1464-410X.2009.08483.x","article-title":"Long-term changes in bone mineral density and predicted fracture risk in patients receiving androgen-deprivation therapy for prostate cancer, with stratification of treatment based on presenting values","volume":"104","author":"Wadhwa","year":"2009","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.ejca.2012.01.035_b0060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/00365590701673625","article-title":"Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005","volume":"41","author":"Adolfsson","year":"2007","journal-title":"Scand J Urol Nephrol"},{"issue":"1","key":"10.1016\/j.ejca.2012.01.035_b0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/02841860802247664","article-title":"The completeness of the Swedish Cancer Register: a sample survey for year 1998","volume":"48","author":"Barlow","year":"2009","journal-title":"Acta Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2012.01.035_b0070","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/00365590903024577","article-title":"PCBaSe Sweden: a register-based resource for prostate cancer research","volume":"43","author":"Hagel","year":"2009","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.ejca.2012.01.035_b0075","unstructured":"The National Board of Health and Welfare. Statistics in the Areas of Health and, Medical Care; 2007."},{"key":"10.1016\/j.ejca.2012.01.035_b0080","unstructured":"Central Bureau for Statistics. Statistics Sweden. http:\/\/www.scb.se\/."},{"key":"10.1016\/j.ejca.2012.01.035_b0085","unstructured":"Rothman K, Greenland S, Lash T. Measures of Effect and Measures of Association. Modern Epidemiology. Philadelphia: Lippincott, Williams & Wilkins; 2008."},{"issue":"5","key":"10.1016\/j.ejca.2012.01.035_b0090","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1470-2045(10)70038-3","article-title":"Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden","volume":"11","author":"Van Hemelrijck","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2012.01.035_b0095","first-page":"406","article-title":"Statistical methods in cancer research. Volume II \u2013 The design and analysis of cohort studies","volume":"82","author":"Breslow","year":"1987","journal-title":"IARC Sci Publ"},{"issue":"5","key":"10.1016\/j.ejca.2012.01.035_b0100","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ejca.2007.12.003","article-title":"Risk of second primary malignancies and causes of death in patients with adenocarcinoma and carcinoid of the small intestine","volume":"44","author":"Zar","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2012.01.035_b0105","doi-asserted-by":"crossref","unstructured":"Van Hemelrijck M, Garmo H, Holmberg L, et al. Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden. J Clin Oncol. 20;28(21):3448\u20133456.","DOI":"10.1200\/JCO.2010.29.1567"},{"key":"10.1016\/j.ejca.2012.01.035_b0110","doi-asserted-by":"crossref","unstructured":"Alibhai SM, Duong-Hua M, Cheung AM, et al. Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 men. J Urol. 184(3):918\u2013923.","DOI":"10.1016\/j.juro.2010.04.068"},{"issue":"11","key":"10.1016\/j.ejca.2012.01.035_b0115","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1002\/cncr.24283","article-title":"Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer","volume":"115","author":"Taylor","year":"2009","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ejca.2012.01.035_b0120","doi-asserted-by":"crossref","first-page":"E456","DOI":"10.1210\/jc.2010-0902","article-title":"Structural decay of bone microarchitecture in men with prostate cancer treated with androgen deprivation therapy","volume":"95","author":"Hamilton","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ejca.2012.01.035_b0125","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-5347(05)64561-2","article-title":"Skeletal fractures negatively correlate with overall survival in men with prostate cancer","volume":"168","author":"Oefelein","year":"2002","journal-title":"J Urol"},{"issue":"6 Pt 1","key":"10.1016\/j.ejca.2012.01.035_b0130","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1097\/01.ju.0000127738.94221.da","article-title":"Bicalutamide 150mg maintains bone mineral density during monotherapy for localized or locally advanced prostate cancer","volume":"171","author":"Sieber","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ejca.2012.01.035_b0135","doi-asserted-by":"crossref","unstructured":"Albertsen PC, Moore DF, Shih W, Lin Y, Li H, Lu-Yao GL. Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol. 1;29(10):1335\u20131341.","DOI":"10.1200\/JCO.2010.31.2330"},{"issue":"1","key":"10.1016\/j.ejca.2012.01.035_b0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.critrevonc.2005.08.003","article-title":"Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study","volume":"58","author":"Houterman","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"10.1016\/j.ejca.2012.01.035_b0145","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/sim.4780020222","article-title":"The need for randomization in the study of intended effects","volume":"2","author":"Miettinen","year":"1983","journal-title":"Stat Med"},{"key":"10.1016\/j.ejca.2012.01.035_b0150","doi-asserted-by":"crossref","unstructured":"Lee RJ, Saylor PJ, Smith MR. Treatment and prevention of bone complications from prostate cancer. Bone. 1;48(1):88\u201395.","DOI":"10.1016\/j.bone.2010.05.038"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912001001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804912001001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T23:05:31Z","timestamp":1561417531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804912001001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0959804912001001"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2012.01.035","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}